Smith+Nephew A.I CyberSecurity Scoring
01/04/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Smith+Nephew in 2026.
No incidents recorded for Smith+Nephew in 2026.
No incidents recorded for Smith+Nephew in 2026.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Latest updates, reports, and threat intel affecting the global network.
Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for...
LINKÖPING, Sweden, Oct. 16, 2025 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra(STO: SECT B) has expanded...
KARL STORZ, a leader in endoscopic imaging and operating room (OR) integration, is proud to announce that the IMAGE1 S® CONNECT II camera...
The company appoints Andreas Martin as Strategic Account Executive in New Zealand to enhance support for MSPs in the region.
Monika Zihlmann, Vice President Global Digital Commercial Platforms at Smith+Nephew, discusses the trends and pressures shaping the medtech industry and...
Smith+Nephew's new robotics research center further solidifies the Pittsburgh area's international robotics standing, but more importantly it will bolster...
The company will advance its innovations in robotics-assisted surgery, continuing the work it began in the city after acquiring Blue Belt...
Authentication bypass using an alternate path or channel vulnerability in N-able N-central allows Authentication Bypass. This issue affects N-central: through 2026.1.
Improper Verification of Cryptographic Signature in ueberauth guardian allows an unauthenticated attacker to revoke a victim's session with a forged token. Guardian.revoke/3 in lib/guardian.ex decodes the supplied token with peek/1, which performs no signature verification (it only base64-decodes the JWT header and payload). The resulting unverified claims are forwarded directly to the configured token module's revoke callback and the implementation's on_revoke callback, a state-mutating sink. The sibling operations refresh/2 and exchange/4 both call decode_and_verify first, so the signature is checked before anything acts on the claims; revoke/3 is the only state-mutating path that acts on claims without verifying the signature. An attacker who knows or guesses a victim's identifying claim values (jti, sub) can forge a JWT carrying those claims, sign it with an arbitrary key, and submit it to any endpoint that funnels a caller-supplied token into Guardian.revoke/3 (the standard logout / session-revocation pattern). When the token module mutates state keyed by the claims (whitelist deletion or blacklist insertion, for example a GuardianDb-style store), the victim's legitimate session is evicted. This is an unauthenticated session-revocation denial of service; the attacker never needs the signing secret. This issue affects guardian: from 1.0.0 before 2.4.1.
Allocation of Resources Without Limits or Throttling vulnerability in ueberauth guardian (Guardian.Permissions module) allows a denial of service via BEAM atom-table exhaustion. This vulnerability is associated with program file lib/guardian/permissions.ex and program routines 'Elixir.Guardian.Permissions':encode_permissions!/1, 'Elixir.Guardian.Permissions':encode_permissions_into_claims!/2, 'Elixir.Guardian.Permissions':do_encode_permissions!/2. The Guardian.Permissions mixin installs a public encode_permissions!/1 function on every module that does use Guardian.Permissions. For each key of the supplied map, encode_permissions!/1 calls String.to_atom(to_string(k)) before any validation runs. The integer-value clause of do_encode_permissions!/2 then short-circuits straight to encoding without validating the key against the configured permission set, so a key with an integer value is interned as a fresh atom with no exception raised. Atoms are never garbage collected and the BEAM atom table is a fixed-size resource (default roughly 1,048,576 entries), so each unique attacker-chosen key permanently consumes one slot. An attacker who can influence a permission map that reaches encode_permissions!/1 (for example a permissions map read from a request body and passed into token issuance via encode_permissions_into_claims!/2) can mint an unbounded number of atoms and exhaust the atom table, crashing the entire BEAM node and every service running on it. The sibling decode_permissions/1 is not affected because it skips keys absent from the configured permission set. This issue affects guardian: from 2.0.0 before 2.4.1.
Allocation of Resources Without Limits or Throttling in ueberauth guardian allows denial of service via unbounded atom creation from attacker-controlled binary input. Guardian.Permissions.AtomEncoding encodes permission scopes by passing arbitrary binaries to String.to_atom/1. When encode/3 in lib/guardian/permissions/atom_encoding.ex is called with a list, each binary entry is handled by the encode_value/3 binary clause, which calls String.to_atom(value) with no allow-list check. The perm_set argument (the application's small, finite set of legitimate permission names) is discarded, so any external string flows straight into atom creation. This encoder is selected with use Guardian.Permissions, encoding: Guardian.Permissions.AtomEncoding and reached through the imported encode/3 entry point. String.to_atom/1 creates a brand-new atom for every previously unseen binary, atoms are never garbage collected, and the BEAM atom table is fixed at roughly 1,048,576 entries by default. An application that funnels attacker-influenced permission scopes (from a request body, a JWT claim, or other external input) into encode/3 therefore mints one permanent atom per distinct value. A modest stream of varied, unauthenticated input permanently consumes the atom table and crashes the BEAM node with system_limit, taking down every application running on it. The default encoder is Guardian.Permissions.BitwiseEncoding, which is not affected. This issue affects guardian: from 2.0.0 before 2.4.1.
Allocation of Resources Without Limits or Throttling in ueberauth guardian allows denial of service via unbounded atom creation from attacker-influenced binary input. Guardian.Plug.Keys derives connection and session namespace keys by passing arbitrary binaries to String.to_atom/1. base_key/1 in lib/guardian/plug/keys.ex converts any binary into the atom :"guardian_<input>", and the derived helpers claims_key/1, resource_key/1, and token_key/1 create a second atom on top of that. key_from_other/1 likewise converts a regex-captured binary through String.to_atom/1. The public specs advertise String.t() as a valid argument, so passing a string is documented usage, and higher-level entry points such as Guardian.Plug.current_token(conn, key: key) thread the caller-supplied key straight into these functions. String.to_atom/1 creates a brand-new atom for every previously unseen binary, atoms are never garbage collected, and the BEAM atom table is fixed at roughly 1,048,576 entries by default. An application that routes attacker-influenced data (a tenant identifier, header, or other request input) into a Guardian key therefore mints one permanent atom per distinct value. A modest stream of varied, unauthenticated input permanently consumes the atom table and crashes the BEAM node, taking down every application running on it. This issue affects guardian: from 0.1.0 before 2.4.1.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.